Sarepta Theraps Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAREPTA THERAPS INC, and what generic alternatives to SAREPTA THERAPS INC drugs are available?
SAREPTA THERAPS INC has three approved drugs.
There are twenty-three US patents protecting SAREPTA THERAPS INC drugs.
There are one hundred and forty-six patent family members on SAREPTA THERAPS INC drugs in twenty-six countries.
Summary for Sarepta Theraps Inc
| International Patents: | 146 |
| US Patents: | 23 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Sarepta Theraps Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-002 | Sep 19, 2016 | RX | Yes | Yes | 9,506,058 | See Plans and Pricing | See Plans and Pricing | ||||
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-001 | Sep 19, 2016 | RX | Yes | Yes | 10,364,431 | See Plans and Pricing | See Plans and Pricing | ||||
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-001 | Sep 19, 2016 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| Sarepta Theraps Inc | AMONDYS 45 | casimersen | SOLUTION;INTRAVENOUS | 213026-001 | Feb 25, 2021 | RX | Yes | Yes | RE48960 | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Sarepta Theraps Inc | VYONDYS 53 | golodirsen | SOLUTION;INTRAVENOUS | 211970-001 | Dec 12, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| Sarepta Theraps Inc | EXONDYS 51 | eteplirsen | SOLUTION;INTRAVENOUS | 206488-001 | Sep 19, 2016 | RX | Yes | Yes | RE48468 | See Plans and Pricing | See Plans and Pricing | ||||
| Sarepta Theraps Inc | VYONDYS 53 | golodirsen | SOLUTION;INTRAVENOUS | 211970-001 | Dec 12, 2019 | RX | Yes | Yes | 10,266,827 | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sarepta Theraps Inc
International Patents for Sarepta Theraps Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1245325 | See Plans and Pricing |
| Hong Kong | 1245670 | See Plans and Pricing |
| Japan | 2012506697 | See Plans and Pricing |
| Spain | 2639852 | See Plans and Pricing |
| Hong Kong | 1216545 | See Plans and Pricing |
| Germany | 602005026386 | See Plans and Pricing |
| European Patent Office | 3228711 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
